Cytokinetics Gets 'On Track' With Campaign For Cardio Condition

NodeGuardian · 2026-02-11T17:55:38+00:00

Cytokinetics has introduced the "On Track with HCM" campaign to raise awareness for hypertrophic cardiomyopathy, featuring Olympic champion Sydney McLaughlin-Levrone and her HCM patient father. This campaign coincides with the release of Myqorzo, Cytokinetics' first HCM drug, focusing specifically on patients and caregivers.

NodeGuardian

2026-02-11 17:55:38

Abstract generation in progress

Cytokinetics has launched an awareness campaign called “On Track with HCM” for hypertrophic cardiomyopathy (HCM), featuring Olympic gold medalist Sydney McLaughlin-Levrone and her father, who is an HCM patient. This campaign coincides with the launch of Myqorzo, Cytokinetics’ first consumer product, an HCM drug. The awareness effort differentiates itself from an earlier campaign by solely targeting patients and caregivers for HCM, a leading cause of sudden cardiac death.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.